ZTBus: A Dataset of 1000+ Complete, Second-Resolved Driving Missions of Inner-City Transit Buses

This paper presents the Zurich Transit Bus (ZTBus) dataset, which consists of data recorded during driving missions of electric city buses in Zurich, Switzerland. The data was collected over several years on two trolley buses as part of multiple research projects. It involves more than a thousand missions across all seasons, each mission usually covering a full day of operation. The ZTBus dataset contains detailed information on the vehicle's power demand, propulsion system, odometry, global position, ambient temperature, door openings, number of passengers, dispatch patterns within the public transportation network, etc. All signals are synchronized in time and include an absolute timestamp in tabular form. The dataset can be used as a foundation for a variety of studies and analyses. For example, the data can serve as a basis for simulations to estimate the performance of different public transit vehicle types, or to evaluate and optimize control strategies of hybrid electric vehicles. Furthermore, numerous influencing factors on vehicle operation, such as traffic, passenger volume, etc., can be analyzed in detail.Comment: This work has been submitted to Scientific Data for possible publicatio

Highly Efficient Year-Round Energy and Comfort Optimization of HVAC Systems in Electric City Buses

In this paper, we present a novel approach to perform highly efficient numerical simulations of the heating, ventilation, and air-conditioning (HVAC) system of an electric city bus. The models for this simulation are based on the assumption of a steady-state operation. We show two approaches to obtain the minimum energy requirement for a certain thermal comfort criterion under specific ambient conditions. Due to the computationally efficient approach developed, we can evaluate the model on a large dataset of 7500 scenarios in various ambient conditions to estimate the year-round performance of the system subject to different comfort requirements. Compared to a heating strategy based on positive temperature coefficient (PTC) elements, we can thus show that a heat pump (HP) can reduce the annual mean power consumption by up to 60%. Ceiling-mounted radiant heating elements complementing a PTC heating system can reduce the annual mean power consumption by up to 10%, while they cannot improve the energy efficiency when used in conjunction with a HP. Finally, a broad sensitivity study reveals the fact that improving the HP's heating-mode coefficient of performance (COP) manifests the largest leverage in terms of mean annual power consumption. Moreover, the annual energy expenditure for cooling are around eight times smaller than those for heating. The case study considered thus reveals that the advantages of improving the COP of the cooling mode are significantly lower.Comment: This work has been accepted to IFAC for publication under a Creative Commons Licence CC-BY-NC-N

Campaña de excavaciones 1995 [Material gráfico]

Detalle de los trabajos del levantamiento de materiales arqueológicos del Sector 84 Corte A/E-4/9INCLUIDAS EN EL ALBUM 1 DE CPG-95Copia digital. Madrid : Ministerio de Educación, Cultura y Deporte. Subdirección General de Coordinación Bibliotecaria, 201

Engine knock margin control using in-cylinder pressure data: preliminary results

Knock is an undesired phenomenon occurring in spark ignited engines and is controlled acting on the spark timing. This paper presents a closed-loop architecture that makes possible to address the knock control problem with a standard model-based design approach. An engine knock margin estimate is feedback controlled through a PI regulator and its target value is computed starting from the desired knock probability. A black-box modelling approach is used to identify the dynamics between the spark timing and the knock margin and a traditional model-based controller synthesis is performed. Experimental results at the test bench show that, compared to a conventional strategy, the proposed approach allows for a better compromise between the controller speed and the variability of the spark timing. Moreover, another advantage w.r.t. the conventional strategies is that closed-loop performance prove to be constant for different reference probabilities, leading to a more regular engine behaviour

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.

BACKGROUND: Allogeneic bone marrow transplantation (allo-BMT) is a potentially curative therapy for a variety of hematologic diseases, but benefits, including graft-versus-tumor (GVT) activity are limited by graft-versus-host-disease (GVHD). Carcinoembryonic antigen related cell adhesion molecule 1 (Ceacam1) is a transmembrane glycoprotein found on epithelium, T cells, and many tumors. It regulates a variety of physiologic and pathological processes such as tumor biology, leukocyte activation, and energy homeostasis. Previous studies suggest that Ceacam1 negatively regulates inflammation in inflammatory bowel disease models. METHODS: We studied Ceacam1 as a regulator of GVHD and GVT after allogeneic bone marrow transplantation (allo-BMT) in mouse models. In vivo, Ceacam1(-/-) T cells caused increased GVHD mortality and GVHD of the colon, and greater numbers of donor T cells were positive for activation markers (CD25(hi), CD62L(lo)). Additionally, Ceacam1(-/-) CD8 T cells had greater expression of the gut-trafficking integrin α(4)β(7), though both CD4 and CD8 T cells were found increased numbers in the gut post-transplant. Ceacam1(-/-) recipients also experienced increased GVHD mortality and GVHD of the colon, and alloreactive T cells displayed increased activation. Additionally, Ceacam1(-/-) mice had increased mortality and decreased numbers of regenerating small intestinal crypts upon radiation exposure. Conversely, Ceacam1-overexpressing T cells caused attenuated target-organ and systemic GVHD, which correlated with decreased donor T cell numbers in target tissues, and mortality. Finally, graft-versus-tumor survival in a Ceacam1(+) lymphoma model was improved in animals receiving Ceacam1(-/-) vs. control T cells. CONCLUSIONS: We conclude that Ceacam1 regulates T cell activation, GVHD target organ damage, and numbers of donor T cells in lymphoid organs and GVHD target tissues. In recipients of allo-BMT, Ceacam1 may also regulate tissue radiosensitivity. Because of its expression on both the donor graft and host tissues, this suggests that targeting Ceacam1 may represent a potent strategy for the regulation of GVHD and GVT after allogeneic transplantation

Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia

Background: chronic lymphocytic leukemia (CLL) primarily affects older persons who often have coexisting conditions in addition to disease-related immunosuppression and myelosuppression. We conducted an international, open-label, randomized phase 3 trial to compare two oral agents, ibrutinib and chlorambucil, in previously untreated older patients with CLL or small lymphocytic lymphoma. Methods: we randomly assigned 269 previously untreated patients who were 65 years of age or older and had CLL or small lymphocytic lymphoma to receive ibrutinib or chlorambucil. The primary end point was progression-free survival as assessed by an independent review committee. Results: the median age of the patients was 73 years. During a median follow-up period of 18.4 months, ibrutinib resulted in significantly longer progression-free survival than did chlorambucil (median, not reached vs. 18.9 months), with a risk of progression or death that was 84% lower with ibrutinib than that with chlorambucil (hazard ratio, 0.16; P<0.001). Ibrutinib significantly prolonged overall survival; the estimated survival rate at 24 months was 98% with ibrutinib versus 85% with chlorambucil, with a relative risk of death that was 84% lower in the ibrutinib group than in the chlorambucil group (hazard ratio, 0.16; P=0.001). The overall response rate was higher with ibrutinib than with chlorambucil (86% vs. 35%, P<0.001). The rates of sustained increases from baseline values in the hemoglobin and platelet levels were higher with ibrutinib. Adverse events of any grade that occurred in at least 20% of the patients receiving ibrutinib included diarrhea, fatigue, cough, and nausea; adverse events occurring in at least 20% of those receiving chlorambucil included nausea, fatigue, neutropenia, anemia, and vomiting. In the ibrutinib group, four patients had a grade 3 hemorrhage and one had a grade 4 hemorrhage. A total of 87% of the patients in the ibrutinib group are continuing to take ibrutinib. Conclusions: ibrutinib was superior to chlorambucil in previously untreated patients with CLL or small lymphocytic lymphoma, as assessed by progression-free survival, overall survival, response rate, and improvement in hematologic variables. (Funded by Pharmacyclics and others; RESONATE-2 ClinicalTrials.gov number, NCT01722487.)

Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL

Microenvironment and activation signals likely imprint heterogeneity in the lymphatic endothelial cell (LEC) population. Particularly LECs of secondary lymphoid organs are exposed to different cell types and immune stimuli. However, our understanding of the nature of LEC activation signals and their cell source within the secondary lymphoid organ in the steady state remains incomplete. Here we show that integrin alpha 2b (ITGA2b), known to be carried by platelets, megakaryocytes and hematopoietic progenitors, is expressed by a lymph node subset of LECs, residing in medullary, cortical and subcapsular sinuses. In the subcapsular sinus, the floor but not the ceiling layer expresses the integrin, being excluded from ACKR4+LECs but overlapping with MAdCAM-1 expression. ITGA2b expression increases in response to immunization, raising the possibility that heterogeneous ITGA2b levels reflect variation in exposure to activation signals. We show that alterations of the level of receptor activator of NF-κB ligand (RANKL), by overexpression, neutralization or deletion from stromal marginal reticular cells, affected the proportion of ITGA2b+LECs. Lymph node LECs but not peripheral LECs express RANK. In addition, we found that lymphotoxin-β receptor signaling likewise regulated the proportion of ITGA2b+LECs. These findings demonstrate that stromal reticular cells activate LECs via RANKL and support the action of hematopoietic cell-derived lymphotoxin

Application and quality assessment of an instantaneous vehicle emission model at fleet level

ISSN:1420-2026ISSN:1573-296

System Design and Analysis of a Directly Air-Assisted Turbocharged SI Engine with Camshaft Driven Valves

The availability of compressed air in combination with downsizing and turbocharging is a promising approach to improve the fuel economy and the driveability of internal combustion engines. The compressed air is used to boost and start the engine. It is generated during deceleration phases by running the engine as a piston compressor. In this paper, a camshaft-driven valve is considered for the control of the air exchange between the tank and the combustion chamber. Such a valve system is cost-effective and robust. Each pneumatic engine mode is realized by a separate cam. The air mass transfer in each mode is analyzed. Special attention is paid to the tank pressure dependence. The air demand in the boost mode is found to increase with the tank pressure. However, the dependence on the tank pressure is small in the most relevant operating region. The air demand of the pneumatic start shows a piecewise continuous dependence on the tank pressure. Finally, a tank sizing method is proposed which uses a quasi-static simulation. It is applied to a compact class vehicle, for which a tank volume of less than 10 L is sufficient. A further reduction of the tank volume is limited by the specifications imposed on the pneumatic start.ISSN:1996-107